T L Darrow - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

T L Darrow

Showing results (1-10 of 34) with videos related to

Pageof 4

Sort By:

Cellular Immunology|November 1, 1980

Prostaglandin-mediated regulation of the mixed lymphocyte culture and generation of cytotoxic cellsT L Darrow, R H Tomar

Cancer Research|April 15, 1997

Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cellsS Yang, T L Darrow, H F Seigler

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1989

The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigensT L Darrow, C L Slingluff, H F Seigler

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983

Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybridsD L Toffaletti, T L Darrow, D W Scott

Current Surgery|September 1, 1989

Generation of autologous tumor-specific cytotoxic T-cells using HLA-A region matched allogeneic melanomaN J Crowley, T L Darrow, H F Seigler

Cellular Immunology|May 15, 1981

Response to and production of prostaglandin by murine thymus, spleen, bone marrow, and lymph node cellsR H Tomar, T L Darrow, P A John

Annals of Surgery|August 1, 1989

Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapyC L Slingluff, T L Darrow, H F Seigler

Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1987

Human T cells specifically activated against autologous malignant melanomaC L Slingluff, T L Darrow, H F Seigler

Cancer|July 1, 1988

Autologous lymph node cell-derived tumor-specific cytotoxic T-cells for use in adoptive immunotherapy of human melanomaT L Darrow, C L Slingluff, H F Seigler

Cellular Immunology|August 25, 2001

Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cellsR Zennadi, Z Abdel-Wahab, H F Seigler, et al.

Pageof 4

Search research articles

Showing results (1-10 of 34) with videos related to

Sort By:

Pageof 4

Cellular Immunology|November 1, 1980

Prostaglandin-mediated regulation of the mixed lymphocyte culture and generation of cytotoxic cellsT L Darrow, R H Tomar

Cancer Research|April 15, 1997

Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cellsS Yang, T L Darrow, H F Seigler

Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1989

The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigensT L Darrow, C L Slingluff, H F Seigler

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983

Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybridsD L Toffaletti, T L Darrow, D W Scott

Current Surgery|September 1, 1989

Generation of autologous tumor-specific cytotoxic T-cells using HLA-A region matched allogeneic melanomaN J Crowley, T L Darrow, H F Seigler

Cellular Immunology|May 15, 1981

Response to and production of prostaglandin by murine thymus, spleen, bone marrow, and lymph node cellsR H Tomar, T L Darrow, P A John

Annals of Surgery|August 1, 1989

Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapyC L Slingluff, T L Darrow, H F Seigler

Archives of Surgery (Chicago, Ill. : 1960)|December 1, 1987

Human T cells specifically activated against autologous malignant melanomaC L Slingluff, T L Darrow, H F Seigler

Cancer|July 1, 1988

Autologous lymph node cell-derived tumor-specific cytotoxic T-cells for use in adoptive immunotherapy of human melanomaT L Darrow, C L Slingluff, H F Seigler

Cellular Immunology|August 25, 2001

Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cellsR Zennadi, Z Abdel-Wahab, H F Seigler, et al.

Pageof 4